Stay updated on Pembrolizumab in HER2+ Gastric Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HER2+ Gastric Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added a 'Gastric cancer' tag and a link to the Genetic and Rare Diseases Information Center; page revision updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-14T11:08:04.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.4.1' appears and the previous 'Revision: v3.4.0' label is removed; this is a minor version update not affecting trial details.
    Difference
    0.0%
    Check dated 2026-02-07T06:42:28.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page adds a glossary toggle and new metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted) plus an updated revision label (v3.4.0). It removes older items (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-24T01:18:57.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T01:01:42.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The Study Details page has expanded the Contacts and Locations section with a comprehensive list of new sites across the United States and other countries. This increases accessibility for potential participants by showing where enrollment is available.
    Difference
    3%
    Check dated 2025-12-19T12:58:54.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Completed status was added and the previous 'Active, not recruiting' status was removed. The latest update was posted in November 2025, indicating the trial has finished enrollment and data collection.
    Difference
    0.1%
    Check dated 2025-12-12T11:20:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HER2+ Gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.